Intensity Therapeutics Statistics
Total Valuation
INTS has a market cap or net worth of $54.70 million. The enterprise value is $40.06 million.
| Market Cap | 54.70M |
| Enterprise Value | 40.06M |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, after market close.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
INTS has 13.71 million shares outstanding. The number of shares has increased by 152.67% in one year.
| Shares Outstanding | 13.71M |
| Shares Change (YoY) | +152.67% |
| Shares Change (QoQ) | -36.93% |
| Owned by Insiders (%) | 39.13% |
| Owned by Institutions (%) | 9.66% |
| Float | 6.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.16 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.91 |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.55 |
Financial Efficiency
Return on equity (ROE) is -168.00% and return on invested capital (ROIC) is -62.55%.
| Return on Equity (ROE) | -168.00% |
| Return on Assets (ROA) | -89.00% |
| Return on Capital (ROIC) | -62.55% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.37M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 4.32 |
| 200-Day Moving Average | 4.77 |
| Relative Strength Index (RSI) | 40.56 |
| Average Volume (30 Days) | 51,743 |
Short Selling Information
The latest short interest is 27,356, so 0.20% of the outstanding shares have been sold short.
| Short Interest | 27,356 |
| Short Previous Month | 14,551 |
| Short % of Shares Out | 0.20% |
| Short % of Float | 0.40% |
| Short Ratio (days to cover) | 0.44 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.32M |
| Pretax Income | -10.54M |
| Net Income | -11.86M |
| EBITDA | -10.09M |
| EBIT | -10.23M |
| Earnings Per Share (EPS) | -$1.38 |
Balance Sheet
The company has $14.78 million in cash and $138,000 in debt, giving a net cash position of $14.64 million or $1.07 per share.
| Cash & Cash Equivalents | 14.78M |
| Total Debt | 138,000 |
| Net Cash | 14.64M |
| Net Cash Per Share | $1.07 |
| Equity / Book Value | 13.16M |
| Book Value Per Share | 0.96 |
| Working Capital | 11.51M |
Cash Flow
| Operating Cash Flow | -7.21M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.21M |
| FCF Per Share | -$0.84 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INTS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -152.67% |
| Shareholder Yield | -152.67% |
| Earnings Yield | -21.69% |
| FCF Yield | -13.17% |
Analyst Forecast
The average price target for INTS is $12.00, which is 200.75% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.00 |
| Price Target Difference | 200.75% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |